Myeloid Infection Links Epithelial and B Cell Tropisms of Murid Herpesvirus-4

PLoS Pathogens

Volumn 8, Issue 9, 2012, Pages

  Frederico, Bruno ^a   Milho, Ricardo ^a   May, Janet S ^a   Gillet, Laurent ^a,b   Stevenson, Philip G ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; BONE MARROW CELL; CELL FREE SYSTEM; CELL PERMEABILIZATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; FIBROBLAST; FLOW CYTOMETRY; HERPES VIRUS INFECTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LOXP SITE; LYMPHOCYTE; LYMPHOID TISSUE; MACROPHAGE; MICROBIAL COLONIZATION; MOUSE; MURID HERPESVIRUS 4; MURIDAE; NONHUMAN; PROTEIN EXPRESSION; RHADINOVIRUS; TROPISM; VIRION; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS STRAIN;

3T3 CELLS; ANIMALS; ANTIGENS, CD11C; B-LYMPHOCYTES; CELL LINE; CRICETINAE; EPITHELIAL CELLS; FIBROBLASTS; HEK293 CELLS; HERPESVIRIDAE INFECTIONS; HUMANS; MACROPHAGES; MICE; MICE, INBRED C57BL; MYELOID CELLS; RHADINOVIRUS; TUMOR VIRUS INFECTIONS; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

HUMAN HERPESVIRUS 8; MURID HERPESVIRUS 4; RHADINOVIRUS;

EID: 84866914719     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002935     Document Type: Article

References (68)

1. Hutt-Fletcher LM, (2007) Epstein-Barr virus entry. J Virol 81: 7825-7832.
2. Faulkner GC, Krajewski AS, Crawford DH, (2000) The ins and outs of EBV infection. Trends Microbiol 8: 185-189.
3. Hassman LM, Ellison TJ, Kedes DH, (2011) KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation. J Clin Invest 121: 752-768.
4. Hoagland RJ, (1964) The incubation period of infectious mononucleosis. Am J Public Health Nations Health 54: 1699-1705.
5. Sokal EM, Hoppenbrouwers K, Vandermeulen C, Moutschen M, Léonard P, et al. (2007) Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy f an Epstein-Barr virus vaccine in healthy young adults. J Infect Dis 196: 1749-1753.
6. Barton E, Mandal P, Speck SH, (2011) Pathogenesis and host control of gammaherpesviruses: lessons from the mouse. Annu Rev Immunol 29: 351-397.
7. Flaño E, Woodland DL, Blackman MA, (2002) A mouse model for infectious mononucleosis. Immunol Res 25: 201-217.
8. Nash AA, Dutia BM, Stewart JP, Davison AJ, (2001) Natural history of murine gamma-herpesvirus infection. Philos Trans R Soc Lond 356: 569-579.
9. Stevenson PG, Simas JP, Efstathiou S, (2009) Immune control of mammalian gamma-herpesviruses: lessons from murid herpesvirus-4. J Gen Virol 90: 2317-2330.
10. Efstathiou S, Ho YM, Hall S, Styles CJ, Scott SD, et al. (1990) Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. J Gen Virol 71: 1365-1372.
11. Virgin HW, Latreille P, Wamsley P, Hallsworth K, Weck KE, et al. (1997) Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71: 5894-5904.
12. Sunil-Chandra NP, Efstathiou S, Nash AA, (1992) Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol 73: 3275-3279.
13. Flaño E, Husain SM, Sample JT, Woodland DL, Blackman MA, (2000) Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J Immunol 165: 1074-1081.
14. Stewart JP, Usherwood EJ, Ross A, Dyson H, Nash T, (1998) Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J Exp Med 187: 1941-1951.
15. Kayhan B, Yager EJ, Lanzer K, Cookenham T, Jia Q, et al. (2007) A replication-deficient murine gamma-herpesvirus blocked in late viral gene expression can establish latency and elicit protective cellular immunity. J Immunol 179: 8392-8402.
16. Moser JM, Farrell ML, Krug LT, Upton JW, Speck SH, (2006) A gammaherpesvirus 68 gene 50 null mutant establishes long-term latency in the lung but fails to vaccinate against a wild-type virus challenge. J Virol 80: 1592-1598.
17. Milho R, Smith CM, Marques S, Alenquer M, May JS, et al. (2009) In vivo imaging of murid herpesvirus-4 infection. J Gen Virol 90: 21-32.
18. Gaspar M, May JS, Sukla S, Frederico B, Gill MB, et al. (2011) Murid herpesvirus-4 exploits dendritic cells to infect B cells. PLoS Pathog 7: e1002346.
19. Tibbetts SA, Loh J, Van Berkel V, McClellan JS, Jacoby MA, et al. (2003) Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection. J Virol 77: 7696-7701.
20. Forrest JC, Speck SH, (2008) Establishment of B-cell lines latently infected with reactivation-competent murine gammaherpesvirus 68 provides evidence for viral alteration of a DNA damage-signaling cascade. J Virol 82: 7688-7699.
21. Sunil-Chandra NP, Efstathiou S, Nash AA, (1993) Interactions of murine gammaherpesvirus 68 with B and T cell lines. Virology 193: 825-833.
22. Dutia BM, Stewart JP, Clayton RA, Dyson H, Nash AA, (1999) Kinetic and phenotypic changes in murine lymphocytes infected with murine gammaherpesvirus-68 in vitro. J Gen Virol 80: 2729-2736.
23. Stevenson PG, Doherty PC, (1999) Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo. J Virol 73: 1075-1079.
24. de Lima BD, May JS, Stevenson PG, (2004) Murine gammaherpesvirus 68 lacking gp150 shows defective virion release but establishes normal latency in vivo. J Virol 78: 5103-5112.
25. Jarousse N, Chandran B, Coscoy L, (2008) Lack of heparan sulfate expression in B-cell lines: implications for Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 infections. J Virol 82: 12591-12597.
26. Brandtzaeg P, (2011) Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways. Am J Respir Crit Care Med 183: 1595-1604.
27. Sunil-Chandra NP, Efstathiou S, Arno J, Nash AA, (1992) Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J Gen Virol 73: 2347-2356.
28. Bowden RJ, Simas JP, Davis AJ, Efstathiou S, (1997) Murine gammaherpesvirus 68 encodes tRNA-like sequences which are expressed during latency. J Gen Virol 78: 1675-1687.
29. Marques S, Efstathiou S, Smith KG, Haury M, Simas JP, (2003) Selective Gene Expression of Latent Murine Gammaherpesvirus 68 in B Lymphocytes. J Virol 77: 7308-7318.
30. Bennett NJ, May JS, Stevenson PG, (2005) Gamma-herpesvirus latency requires T cell evasion during episome maintenance. PLoS Biol 3: e120.
31. Flaño E, Kim IJ, Woodland DL, Blackman MA, (2002) Gamma-herpesvirus latency is preferentially maintained in splenic germinal center and memory B cells. J Exp Med 196: 1363-1372.
32. Willer DO, Speck SH, (2003) Long-term latent murine Gammaherpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo. J Virol 77: 8310-8321.
33. Gillet L, Adler H, Stevenson PG, (2007) Glycosaminoglycan interactions in murine gammaherpesvirus-68 infection. PLoS ONE 2: e347.
34. David G, Bai XM, Van der Schueren B, Cassiman JJ, Van den Berghe H, (1992) Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol 119: 961-975.
35. Suzuki K, Yamamoto K, Kariya Y, Maeda H, Ishimaru T, et al. (2008) Generation and characterization of a series of monoclonal antibodies that specifically recognize [HexA(+/-2S)-GlcNAc]n epitopes in heparan sulfate. Glycoconj J 25: 703-712.
36. Bernfield M, Götte M, Park PW, Reizes O, Fitzgerald ML, et al. (1999) Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68: 729-777.
37. Gillet L, Colaco S, Stevenson PG, (2008) The Murid Herpesvirus-4 gH/gL Binds to Glycosaminoglycans. PLoS ONE 3: e1669.
38. Smith CM, Gill MB, May JS, Stevenson PG, (2007) Murine gammaherpesvirus-68 inhibits antigen presentation by dendritic cells. PLoS ONE 2: e1048.
39. Peeters B, Pol J, Gielkens A, Moormann R, (1993) Envelope glycoprotein gp50 of pseudorabies virus is essential for virus entry but is not required for viral spread in mice. J Virol 67: 170-177.
40. May JS, Walker J, Colaco S, Stevenson PG, (2005) The murine gammaherpesvirus 68 ORF27 gene product contributes to intercellular viral spread. J Virol 79: 5059-5068.
41. Gillet L, Stevenson PG, (2007) Antibody evasion by the N terminus of murid herpesvirus-4 glycoprotein B. EMBO J 26: 5131-5142.
42. Wright DE, Colaco S, Colaco C, Stevenson PG, (2009) Antibody limits in vivo murid herpesvirus-4 replication by IgG Fc receptor-dependent functions. J Gen Virol 90: 2592-2603.
43. Gillet L, Colaco S, Stevenson PG, (2008) Glycoprotein B switches conformation during murid herpesvirus 4 entry. J Gen Virol 89: 1352-1363.
44. Gillet L, Colaco S, Stevenson PG, (2008) The Murid Herpesvirus-4 gL regulates an entry-associated conformation change in gH. PLoS ONE 3: e2811.
45. Glauser DL, Kratz AS, Stevenson PG, (2012) Herpesvirus glycoproteins undergo multiple antigenic changes before membrane fusion. PLoS One 7: e30152.
46. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Förster I, (1999) Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 8: 265-277.
47. Rickert RC, Roes J, Rajewsky K, (1997) B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res 25: 1317-1318.
48. Caton ML, Smith-Raska MR, Reizis B, (2007) Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. J Exp Med 204: 1653-1664.
49. Sanderson RD, Lalor P, Bernfield M, (1989) B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul 1: 27-35.
50. Jarousse N, Trujillo DL, Wilcox-Adelman S, Coscoy L, (2011) Virally-induced upregulation of heparan sulfate on B cells via the action of type I IFN. J Immunol 187: 5540-5547.
51. Machiels B, Lété C, de Fays K, Mast J, Dewals B, et al. (2011) The bovine herpesvirus 4 Bo10 gene encodes a nonessential viral envelope protein that regulates viral tropism through both positive and negative effects. J Virol 85: 1011-1024.
52. Wykes M, Pombo A, Jenkins C, MacPherson GG, (1998) Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J Immunol 161: 1313-1319.
53. Gillet L, May JS, Stevenson PG, (2009) In vivo importance of heparan sulfate-binding glycoproteins for murid herpesvirus-4 infection. J Gen Virol 90: 602-613.
54. Wang X, Hutt-Fletcher LM, (1998) Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect. J Virol 72: 158-163.
55. Gillet L, May JS, Colaco S, Stevenson PG, (2007) Glycoprotein L disruption reveals two functional forms of the murine gammaherpesvirus 68 glycoprotein H. J Virol 81: 280-291.
56. May JS, Coleman HM, Boname JM, Stevenson PG, (2005) Murine gammaherpesvirus-68 ORF28 encodes a non-essential virion glycoprotein. J Gen Virol 86: 919-928.
57. May JS, de Lima BD, Colaco S, Stevenson PG, (2005) Intercellular gamma-herpesvirus dissemination involves co-ordinated intracellular membrane protein transport. Traffic 6: 780-793.
58. Junt T, Moseman EA, Iannacone M, Massberg S, Lang PA, et al. (2007) Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature 450: 110-114.
59. Hume DA, (2011) Applications of myeloid-specific promoters in transgenic mice support in vivo imaging and functional genomics but do not support the concept of distinct macrophage and dendritic cell lineages or roles in immunity. J Leukoc Biol 89: 525-538.
60. Borza CM, Hutt-Fletcher LM, (2002) Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 8: 594-599.
61. Stevenson PG, May JS, Smith XG, Marques S, Adler H, et al. (2002) K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus. Nat Immunol 3: 733-740.
62. Adler H, Messerle M, Wagner M, Koszinowski UH, (2000) Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J Virol 74: 6964-6974.
63. May JS, Stevenson PG, (2010) Vaccination with murid herpesvirus-4 glycoprotein B reduces viral lytic replication but does not induce detectable virion neutralization. J Gen Virol 91: 2542-2552.
64. Milho R, Gill MB, May JS, Colaco S, Stevenson PG, (2011) In vivo function of the murid herpesvirus-4 ribonucleotide reductase small subunit. J Gen Virol 92: 1550-1560.
65. Smith CM, Rosa GT, May JS, Bennett NJ, Mount AM, et al. (2006) CD4+ T cells specific for a model latency-associated antigen fail to control a gammaherpesvirus in vivo. Eur J Immunol 36: 3186-3197.
66. May JS, Colaco S, Stevenson PG, (2005) Glycoprotein M is an essential lytic replication protein of the murine gammaherpesvirus 68. J Virol 79: 3459-3467.
67. Gill MB, May JS, Colaco S, Stevenson PG, (2010) Important role for the murid herpesvirus 4 ribonucleotide reductase large subunit in host colonization via the respiratory tract. J Virol 84: 10937-10942.
68. Gillet L, Alenquer M, Glauser DL, Colaco S, May JS, et al. (2009) Glycoprotein L sets the neutralization profile of murid herpesvirus 4. J Gen Virol 90: 1202-1214.